RJF Stock Analysis: Raymond James Financial | NYSE
Asset Management | NYSE, USA | Market Cap: 33.806m USD | 12M Return: 9.8% | US7547301090 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 205M
EPS Trend: 93.3%
Qual. Beats: 1
Rev. Trend: 97.9%
Qual. Beats: 0
Warnings
No concerns identified
Tailwinds
No distinct edge detected
Seasonality 11.6 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Raymond James Financial (NYSE: RJF) is a diversified financial services firm founded in 1962 and headquartered in Saint Petersburg, Florida. It operates through five business segments-Private Client Group, Capital Markets, Asset Management, Bank, and Other-serving individuals, corporations, and municipalities across the United States, Canada, and Europe. The Private Client Group delivers wealth management and brokerage services to retail investors, while the Capital Markets segment provides investment banking, equity and debt underwriting, and merger and acquisition advisory. The Asset Management unit offers portfolio management and administrative services to retail and institutional clients, and the Bank segment provides lending products, FDIC-insured deposits, and treasury/liquidity services. The Other segment holds private equity investments, including interests in third-party funds.
The firm is classified within the Investment Banking & Brokerage sub-industry under GICS, reflecting that brokerage, advisory, and capital markets activities-rather than traditional commercial banking-are its primary focus. Raymond James operates as a bank holding company, a regulatory structure also used by large diversified peers such as Morgan Stanley, which permits the firm to gather insured deposits through its banking arm while integrating those balances with its broader brokerage and wealth management platform.
- Fed rate cuts compress Bank net interest margin
- Equity market gains lift wealth management fee revenue
- Investment banking rebound drives Capital Markets segment growth
| Net Income: 2.31b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.02 > 0.02 and ΔFCF/TA 0.08 > 1.0 |
| NWC/Revenue: -261.0% < 20% (prev -283.4%; Δ 22.43% < -1%) |
| CFO/TA 0.03 > 3% & CFO 2.43b > Net Income 2.31b |
| Net Debt (-14.1b) to EBITDA (3.14b): -4.48 < 3 |
| Current Ratio: 0.36 > 1.5 & < 3 |
| Outstanding Shares: last quarter (197.2m) vs 12m ago -4.04% < -2% |
| Gross Margin: 83.54% > 18% (prev 87.25%; Δ -3.71% > 0.5%) |
| Asset Turnover: 18.91% > 50% (prev 18.29%; Δ 0.63% > 0%) |
| Interest Coverage Ratio: 3.37 > 6 (EBIT TTM 2.94b / Interest Expense TTM 873.0m) |
| A: -0.47 (Total Current Assets 24.8b - Total Current Liabilities 69.0b) / Total Assets 94.2b |
| B: 0.16 (Retained Earnings 14.6b / Total Assets 94.2b) |
| C: 0.03 (EBIT TTM 2.94b / Avg Total Assets 89.5b) |
| D: 0.16 (Book Value of Equity 12.7b / Total Liabilities 81.5b) |
| Altman-Z'' = -2.19 = D |
| DSRI: 0.99 (Receivables 5.11b/4.71b, Revenue 16.9b/15.5b) |
| GMI: 1.04 (GM 87.25% / 83.54%) |
| AQI: 0.99 (AQ_t 0.72 / AQ_t-1 0.73) |
| SGI: 1.09 (Revenue 16.9b / 15.5b) |
| TATA: -0.00 (NI 2.31b - CFO 2.43b) / TA 94.2b) |
| Beneish M = -2.93 (Cap -4..+1) = A |
As of August 09, 2026, the stock is trading at USD 176.56 with a total of 409,869 shares traded. Over the past week, the price has changed by +0.33%, over one month by +5.35%, over three months by +15.41% and over the past year by +9.81%.
Current recommended Stop Loss: 170.00 (which is 3.7% or 1.7 ATR below the current price).
Raymond James Financial has received a consensus analysts rating of 3.43. Therefore, it is recommended to hold RJF.
- StrongBuy: 2
- Buy: 2
- Hold: 10
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 185.9 | 5.3% |
P/E Trailing = 15.3426
P/E Forward = 12.5313
P/S = 2.2162
P/B = 2.6619
P/EG = 0.8638
Revenue TTM = 16.9b USD
EBIT TTM = 2.94b USD
EBITDA TTM = 3.14b USD
Long Term Debt = 4.22b USD (from longTermDebt, last fiscal year)
Short Term Debt = 1.80b USD (from shortTermDebt, last quarter)
Debt = 5.64b USD (from shortLongTermDebtTotal, last quarter) + Leases 345.0m
Net Debt = -14.1b USD (calculated: Debt 5.64b - CCE 19.7b)
Enterprise Value = 19.8b USD (33.8b + Debt 5.64b - CCE 19.7b)
Interest Coverage Ratio = 3.37 (Ebit TTM 2.94b / Interest Expense TTM 873.0m)
EV/FCF = 8.79x (Enterprise Value 19.8b / FCF TTM 2.25b)
FCF Yield = 11.37% (FCF TTM 2.25b / Enterprise Value 19.8b)
FCF Margin = 13.27% (FCF TTM 2.25b / Revenue TTM 16.9b)
Net Margin = 13.62% (Net Income TTM 2.31b / Revenue TTM 16.9b)
Gross Margin = 83.54% ((Revenue TTM 16.9b - Cost of Revenue TTM 2.79b) / Revenue TTM)
Gross Margin QoQ = 66.21% (prev 90.54%)
Tobins Q-Ratio = 0.21 (Enterprise Value 19.8b / Total Assets 94.2b)
Interest Expense / Debt = 15.47% (Interest Expense 873.0m / Debt 5.64b)
Taxrate = 21.67% (638.0m / 2.94b)
NOPAT = 2.31b (EBIT 2.94b * (1 - 21.67%))
Current Ratio = 0.36 (Total Current Assets 24.8b / Total Current Liabilities 69.0b)
Debt / Equity = 0.44 (Debt 5.64b / totalStockholderEquity, last quarter 12.7b)
Debt / EBITDA = -4.48 (Net Debt -14.1b / EBITDA 3.14b)
Debt / FCF = -6.26 (Net Debt -14.1b / FCF TTM 2.25b)
Total Stockholder Equity = 12.6b (last 4 quarters mean from totalStockholderEquity)
RoA = 2.58% (Net Income 2.31b / Total Assets 94.2b)
RoE = 18.32% (Net Income TTM 2.31b / Total Stockholder Equity 12.6b)
RoCE = 17.52% (EBIT 2.94b / Capital Employed (Equity 12.6b + L.T.Debt 4.22b))
RoIC = 8.82% (NOPAT 2.31b / Invested Capital 26.2b)
WACC = 9.37% (E(33.8b)/V(39.5b) * Re(8.91%) + D(5.64b)/V(39.5b) * Rd(15.47%) * (1-Tc(0.22)))
Discount Rate = 8.91% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -97.32 | Cagr: -3.45%
[DCF] Terminal Value 74.73% ; FCFF base≈2.13b ; Y1≈2.44b ; Y5≈3.59b
[DCF] Fair Price = 311.4 (EV 45.8b - Net Debt -14.1b = Equity 59.8b / Shares 192.1m; r=9.37% [WACC]; 5y FCF grow 14.94% → 2.50% )
EPS Correlation: 93.25 | EPS CAGR: 12.51% | SUE: 1.03 | # QB: 1
Revenue Correlation: 97.90 | Revenue CAGR: 9.45% | SUE: 0.61 | # QB: 0
EPS current Quarter (2026-12-31): EPS=3.33 | Chg30d=+4.66% | Revisions=-25% | Analysts=12
EPS current Year (2026-09-30): EPS=12.12 | Chg30d=+2.25% | Revisions=-25% | GrowthEPS=+13.7% | GrowthRev=+11.9%
EPS next Year (2027-09-30): EPS=14.18 | Chg30d=+4.94% | Revisions=+0% | GrowthEPS=+17.0% | GrowthRev=+10.9%
[Analyst] Revisions Ratio: -29% (up=1, down=3)